Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes

Endocrinology

Volumn 137, Issue 11, 1996, Pages 4706-4712

  Tafuri, Sherrie R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DEOXYGLUCOSE; GLUCOSE; INSULIN; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR; TROGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GLUCOSE TRANSPORT; IMMUNOBLOTTING; METABOLISM; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROADIPOCYTE;

EID: 0029806069     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.11.8895337     Document Type: Article

References (41)

1. Harris MI 1995 Summary. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (eds) Diabetes in America, ed 2. NIDDK, NIH publication 95-1468. NIH, Bethesda, p 13
2. Fujiwara T, Yoshioka A, Yoshioka T 1980 Characterization of a new oral anti-diabetic agent, CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558
3. Stevenson R, Hutson N, Krupp MN, Volkman R, Holland G, Eggler JF, Clark D, McPherson RK, Hall KL, Danbury BH, Gibbs M, Kreutter D1990 Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic Ob/Ob mice. Diabetes 39:1218-1226
4. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW 1994 A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43:1203-1210
5. Akanuma Y, Kosaka K, Kuzuya T, Shigeta Y, Kaneko T 1993 Clinical evaluation of a new oral hypoglycemic agent CS-045 in NIDDM. Diabetologia [Suppl 1] 36:A182
6. Mimura K, Umeda F, Hiramatsu S, Taniguchi S, Ono Y, Nakashima N, Kobayashi N, Masakado M, Sako Y, Nawata H 1994 Effects of a new oral hypoglycemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabetic Med 11:685-691
7. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J 1994 Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-93
8. Digirolamo M, Newby FD, Lovejoy J 1992 Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J 6:2405-2412
9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
10. Kletzien RF, Clarke SD, Ulrich RG 1991 Enhancement of adipocyte differentiation by an insulin sensitizing agent. Mol Pharmacol 41:393-398
11. Sandouk T, Reda D, Hofmann C 1993 Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264:C1600-C1608
12. Sandouk T, Reda D, Hofmann C 1993 The antidiabetic agent pioglitazone increases the expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133:352-359
13. de Herreros AG, Birnbaum MJ 1989 The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of a novel transporter gene. J Biol Chem 264:19994-19999
14. Umek RM, Friedman AD, Mcknight SL 1991 CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288-292
15. Lin FT, Lane MD 1992 Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 6:533-544
16. Lin FT, Lane MD 1994 CCAAT/enhancer binding protein a is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci 91:8787-8761
17. Freytag S, Geddes T 1992 Reciprocal regulation of adipogenesis by Myc and C/EBPα. Science 256:379-382
18. Wang N-D, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ1995 Impaired homeostasis in C/EBPα knockout mice. Science 269:1108-1112
19. Cao Z, Umek RM, Mcknight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552
20. Weiland M, Schurmann A, Schimidt WF., Joost HG 1990 Development of the hormone-sensitive glucose transport activity in differentiating 3T3-L1 murine fibroblasts. Biochem J 270:331-336
21. Ziehm D, Schurmann A, Weiland M, Joost HG 1992 Biphasic alteration of glucose transport in 3T3-L1 cells during differentiation to the adipocyte-like phenotype. Horm Metab Res 25:71-76
22. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM 1994 mPPARγ. tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234
23. Chawla A, Schwarz EJ, Dimaculanga DD, Lazar MA 1994 Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800
24. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812
25. 2 metabolite binds peroxisome proliferator-activated receptor γ and promoter adipocyte differentiation. Cell 83:813-819
26. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA 1995 Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270:23975-23983
27. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ, a lipid-activated transcription factor. Cell 79:1147-1156
28. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans R, Spiegelman BM 1996 Differential activation of adipogenesis by multiple PPAR isoforms Genes Dev 10:974-984
29. Wu Z, Xie Y, Bucher NLR, Farmer SR 1995 Conditional ectopic expression of C/EBP β in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev 9:2350-2363
30. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Wilson TM, Kliewer SA 1995 An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956
31. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB 1993 Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing Glut4 selectively in adipose tissue. J Biol Chem 268:22243-22246
32. Gulve EA, Ren J-M, Marshell BA, Gao J, Hansen PA, Holloszy JO, Mueckler M 1994 Glucose transport activity in skeletal muscles from transgenic mice overexpressing Glutl. J Biol Chem 269:18366-18370
33. Hansen PA, Gulve EA, Marshell BA, Gao J, Pessln JE, Holloszy JO, Mueckler M 1995 Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J Biol Chem 270:1679-1684
34. Gnudi L, Tozzo E, Shepherd PR, Bliss JL, Kahn BB 1995 High level over-expression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance. Endocrinology 136:995-1002
35. Furuta H, Sowa R, Tabata H, Hirayama J, Negoro T, Sanke T, Nanjo K 1994 Effect of new antidiabetic drug CS-045 on peripheral insulin resistance. J Jpn Diabetes Soc 37:343-348
36. Horikoshi H, Okuno A, Fujiwara T, Shiota M, Sugano T 1993 Peripheral effects of a new antidiabetic agent, CS-045: acute stimulation of insulin-induced glucose uptake in perfused rat hindlimb. Diabetes 42:59A
37. Inoue Y, Tanigawa K, Nakamura S, Tamura K, Kato Y, Nakase A 1993 Effect of CS-045, a new oral antidiabetic agent, on B-cell function in rats after 90% pancreatectomy. Diabetologia 36:A182
38. Lee MK, Miles PDG, Khoursheed M, Gao KM, Moosa AR, Olefsky JM 1994 Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43:1435-1439
39. Auwerx J 1992 Regulation of gene expression fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. Horm Res 38:269-177
40. Mimura K, Umeda F, Hiramatsu S, Taniguchi S, Ono Y, Nakashima N, Kobayashi K, Masakado M, Sako Y, Nawata H 1994 Effects of a new oral hypoglycemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabetic Med 11:685-691
41. McGarry JD 1992 What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:776-770